Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-13 DAWES KAREN A Director Exercise or conversion +2,929 $41.19 $121K 118,982
2021-07-13 DAWES KAREN A Director Sale −441 $201.27 $89K 118,541
2021-07-13 DAWES KAREN A Director Sale −630 $202.29 $127K 117,911
2021-07-13 DAWES KAREN A Director Sale −444 $203.09 $90K 117,467
2021-07-13 DAWES KAREN A Director Sale −5 $204.02 $1K 117,462
2021-07-13 DAWES KAREN A Director Exercise or conversion · Stock Option (Right to Buy) +2,929 0
2021-07-13 DAWES KAREN A Director Exercise or conversion +2,929 $41.19 $121K 118,982
2021-07-13 DAWES KAREN A Director Sale +1,520 $202.23 $307K 117,462
2021-07-13 DAWES KAREN A Director Exercise or conversion · Stock Option (Right to Buy) +2,929 0
2021-06-10 KURIYEL RALF Senior VP, R&D Exercise or conversion +2,557 $59.52 $152K 27,112
2021-06-10 KURIYEL RALF Senior VP, R&D Exercise or conversion +1,045 $86.10 $90K 28,157
2021-06-10 KURIYEL RALF Senior VP, R&D Sale −6,802 $189.19 $1.3M 21,355
2021-06-10 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −2,557 1,354
2021-06-10 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −1,045 2,092
2021-05-19 Hunt Anthony Chief Executive Officer Sale −612 $168.29 $103K 212,150
2021-05-19 Hunt Anthony Chief Executive Officer Sale −2,529 $169.45 $429K 209,621
2021-05-19 Hunt Anthony Chief Executive Officer Sale −7,911 $170.28 $1.3M 201,710
2021-05-19 Hunt Anthony Chief Executive Officer Sale −3,420 $171.32 $586K 198,290
2021-05-19 Hunt Anthony Chief Executive Officer Sale −3,036 $172.52 $524K 195,254
2021-05-19 Hunt Anthony Chief Executive Officer Sale −1,560 $173.19 $270K 193,694

Page 27 of 42 · 832 trades